Institute for OneWorld Health represents (IOWH), company manufacturing medicines for neglected diseases and the first nonprofit pharmaceutical company in the world. Founded in 2000 by Dr. Victoria Hale, IOWH took expired and donated the patent compounds and develop them through all stages of clinical trials and approval of drugs to fight the most devastating diseases in the world, tend to occur in third world countries where the perceived profitable markets do not yet exist. By 2004 IOWH presents its first Phase 3 clinical trial results for Paromomycin, a drug designed for visceral leishmaniasis, which killed as many as 200,000 people each year in India, Bangladesh, Sudan, Brazil, Nepal. His next task was to form partnerships with other organizations in the manufacturing and distribution of drugs. The focus is on strategies for Hale IOWH go ahead with a particular focus on their core competencies and mission. "Hide
by Johanna Mair, Oliver Schoen Source: IESE 33 pages. Publication Date: April 1, 2005. Prod. #: IES109-PDF-ENG
Related Case Solutions & Analyses:
New Leadership at the Portland Public Schools
Proteome Systems Limited: The First Five Years
Beverly Stern: Retail Executive
Bang Networks: The First Customer (B)
Organizational Decline: Stimulus for Innovation
Audio Spotlight
Offshore Drilling Industry
FARGO HEALTH GROUP: MANAGING THE DEMAND FOR MEDICAL EXAMINATIONS USING PREDICTIVE ANALYTICS
Harley Davidson Motor Company
Baria planning solution incorporation: Fixing the sales process
